Skip to main content

Table 3 Multivariate analysis with respect to overall survival (n = 135).

From: Phosphorylated Smad2 in Advanced Stage Gastric Carcinoma

Parameter Risk ratio 95% Confidence interval p-Value
P-Smad2 expression 0.627 0.347-1.133 0.122
   Low vs. high    
Morphologic feature 2.325 1.221-4.388 0.010
   Type 1, 2, and 3 vs. type 4    
Differentiation 2.807 1.251-6.298 0.012
   Intestinal-type vs. Diffuse-type    
Lymph node metastasis (Japanese classification) 1.387 0.689-2.794 0.360
   N0 and N1 vs. N2 and N3    
Peritoneal dissemination 1.097 0.549-2.193 0.793
   Negative vs. positive    
Lymphatic invasion 1.394 0.805-2.413 0.235
   Ly0 and ly1 vs. ly2 and ly3    
Clinical Stage 4.382 1.924-9.978 < 0.001
   I, II, and III vs. IV